PetVivo Holdings, Inc.

OTC:PETVOTC:PETVW

Surgical & Medical Instruments & Apparatus·EDINA, MN

CEO

Lai John

CFO

Lowenthal Garry N

Summary Financials

Revenue

$968,706

+5.6% YoY

FY 2025

Adj. EBITDA

-$10.5M

-1083.4% margin

FY 2025

Net Income

-$11.0M

-1130.9% margin

FY 2025

EPS (Diluted)

-$0.78

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$475,314

FY 2024

Total Debt

$39,020

FY 2022

Net Cash

$436,294

FY 2022

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2025

EV / EBITDA

—

Employees

—

Revenue

$968,706

+5.6% YoY

FY 2025

Adj. EBITDA

-$10.5M

-1083.4% margin

FY 2025

Net Income

-$11.0M

-1130.9% margin

FY 2025

EPS (Diluted)

-$0.78

FY 2025

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$475,314

FY 2024

Total Debt

$39,020

FY 2022

Net Cash

$436,294

FY 2022

Enterprise Value

—

Debt / EBITDA

0.0x

FY 2025

EV / EBITDA

—

Employees

—